ClinicalTrials.gov
ClinicalTrials.gov Menu

LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03103087
Recruitment Status : Active, not recruiting
First Posted : April 6, 2017
Last Update Posted : November 20, 2018
Sponsor:
Information provided by (Responsible Party):
Myovant Sciences GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : September 30, 2019
  Estimated Study Completion Date : February 28, 2020